Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Thymidine phosphorylase mRNA stability and protein levels are increased through ERK-mediated cytoplasmic accumulation of hnRNP K in nasopharyngeal carcinoma cells

Abstract

The cytoplasmic level of heterogeneous nuclear ribonucleoprotein K (hnRNP K) is significantly correlated with the elevated expression of thymidine phosphorylase (TP), and high levels of both proteins are predictive of a poor prognosis in nasopharyngeal carcinoma (NPC). We herein show that TP is highly induced by serum deprivation in NPC cells, and that this is due to an increase in the half-life of the TP mRNA, as shown by nuclear run-on and actinomycin D assays. We further show that the CU-rich element of the TP mRNA directly interacts with hnRNP K, as demonstrated by immunoprecipitation RT–PCR assays, and the nucleus-to-cytoplasm translocation of hnRNP K. Blockade of hnRNP K expression reduces TP expression, suggesting that hnRNP K acts in the upregulation of TP. Mechanistically, both MEK inhibitor and the hnRNP K ERK-phosphoacceptor-site mutant decrease cytoplasmic accumulation of hnRNP K, suggesting that ERK-dependent phosphorylation is critical for TP induction. Furthermore, we found that hnRNP K-mediated TP induction allows NPC cells to resist hypoxia-induced apoptosis. Our results collectively establish the regulation and role of ERK-mediated cytoplasmic accumulation of hnRNP K as an upstream modulator of TP, suggesting that hnRNP K may be an attractive candidate as a future therapeutic target for cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Bomsztyk K, Denisenko O, Ostrowski J . (2004). hnRNP K: one protein multiple processes. Bioessays 26: 629–638.

    Article  CAS  Google Scholar 

  • Carpenter B, McKay M, Dundas SR, Lawrie LC, Telfer C, Murray GI . (2006). Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer. Br J Cancer 95: 921–927.

    Article  CAS  Google Scholar 

  • Chen LC, Hsueh C, Tsang NM, Liang Y, Chang KP, Hao SP et al. (2008). Heterogeneous ribonucleoprotein k and thymidine phosphorylase are independent prognostic and therapeutic markers for nasopharyngeal carcinoma. Clin Cancer Res 14: 3807–3813.

    Article  CAS  Google Scholar 

  • Czyzyk-Krzeska MF, Bendixen AC . (1999). Identification of the poly(C) binding protein in the complex associated with the 3′ untranslated region of erythropoietin messenger RNA. Blood 93: 2111–2120.

    CAS  PubMed  Google Scholar 

  • Dewhirst MW, Cao Y, Moeller B . (2008). Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat Rev Cancer 8: 425–437.

    Article  CAS  Google Scholar 

  • Emerald BS, Chen Y, Zhu T, Zhu Z, Lee KO, Gluckman PD et al. (2007). AlphaCP1 mediates stabilization of hTERT mRNA by autocrine human growth hormone. J Biol Chem 282: 680–690.

    Article  CAS  Google Scholar 

  • Evans JR, Mitchell SA, Spriggs KA, Ostrowski J, Bomsztyk K, Ostarek D et al. (2003). Members of the poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivo. Oncogene 22: 8012–8020.

    Article  Google Scholar 

  • Goto H, Kohno K, Sone S, Akiyama S, Kuwano M, Ono M . (2001). Interferon gamma-dependent induction of thymidine phosphorylase/platelet-derived endothelial growth factor through gamma-activated sequence-like element in human macrophages. Cancer Res 61: 469–473.

    CAS  PubMed  Google Scholar 

  • Griffiths L, Dachs GU, Bicknell R, Harris AL, Stratford IJ . (1997). The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo. Cancer Res 57: 570–572.

    CAS  PubMed  Google Scholar 

  • Habelhah H, Shah K, Huang L, Ostareck-Lederer A, Burlingame AL, Shokat KM et al. (2001). ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation. Nat Cell Biol 3: 325–330.

    Article  CAS  Google Scholar 

  • Hatakeyama H, Kondo T, Fujii K, Nakanishi Y, Kato H, Fukuda S et al. (2006). Protein clusters associated with carcinogenesis, histological differentiation and nodal metastasis in esophageal cancer. Proteomics 6: 6300–6316.

    Article  CAS  Google Scholar 

  • Ikeda R, Che XF, Ushiyama M, Yamaguchi T, Okumura H, Nakajima Y et al. (2006). 2-Deoxy-D-ribose inhibits hypoxia-induced apoptosis by suppressing the phosphorylation of p38 MAPK. Biochem Biophys Res Commun 342: 280–285.

    Article  CAS  Google Scholar 

  • Inoue A, Sawata SY, Taira K, Wadhwa R . (2007). Loss-of-function screening by randomized intracellular antibodies: identification of hnRNP-K as a potential target for metastasis. Proc Natl Acad Sci USA 104: 8983–8988.

    Article  CAS  Google Scholar 

  • Katz M, Amit I, Yarden Y . (2007). Regulation of MAPKs by growth factors and receptor tyrosine kinases. Biochim Biophys Acta 1773: 1161–1176.

    Article  CAS  Google Scholar 

  • Kim E, Lee S, Mian MF, Yun SU, Song M, Yi KS et al. (2006). Crosstalk between Src and major vault protein in epidermal growth factor-dependent cell signalling. FEBS J 273: 793–804.

    Article  CAS  Google Scholar 

  • Kitazono M, Takebayashi Y, Ishitsuka K, Takao S, Tani A, Furukawa T et al. (1998). Prevention of hypoxia-induced apoptosis by the angiogenic factor thymidine phosphorylase. Biochem Biophys Res Commun 253: 797–803.

    Article  CAS  Google Scholar 

  • Lee AW, Poon YF, Foo W, Law SC, Cheung FK, Chan DK et al. (1992). Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976–1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 23: 261–270.

    Article  CAS  Google Scholar 

  • Lee PT, Liao PC, Chang WC, Tseng JT . (2007). Epidermal growth factor increases the interaction between nucleolin and heterogeneous nuclear ribonucleoprotein K/poly(C) binding protein 1 complex to regulate the gastrin mRNA turnover. Mol Biol Cell 18: 5004–5013.

    Article  CAS  Google Scholar 

  • Levy AP, Levy NS, Goldberg MA . (1996). Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J Biol Chem 271: 2746–2753.

    Article  CAS  Google Scholar 

  • Liekens S, Bronckaers A, Perez-Perez MJ, Balzarini J . (2007). Targeting platelet-derived endothelial cell growth factor/thymidine phosphorylase for cancer therapy. Biochem Pharmacol 74: 1555–1567.

    Article  CAS  Google Scholar 

  • Lin JC, Hsu M, Tarn WY . (2007). Cell stress modulates the function of splicing regulatory protein RBM4 in translation control. Proc Natl Acad Sci USA 104: 2235–2240.

    Article  CAS  Google Scholar 

  • Lynch M, Chen L, Ravitz MJ, Mehtani S, Korenblat K, Pazin MJ et al. (2005). hnRNP K binds a core polypyrimidine element in the eukaryotic translation initiation factor 4E (eIF4E) promoter, and its regulation of eIF4E contributes to neoplastic transformation. Mol Cell Biol 25: 6436–6453.

    Article  CAS  Google Scholar 

  • Michael WM, Eder PS, Dreyfuss G . (1997). The K nuclear shuttling domain: a novel signal for nuclear import and nuclear export in the hnRNP K protein. EMBO J 16: 3587–3598.

    Article  CAS  Google Scholar 

  • Notari M, Neviani P, Santhanam R, Blaser BW, Chang JS, Galietta A et al. (2006). A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation. Blood 107: 2507–2516.

    Article  CAS  Google Scholar 

  • Ostareck-Lederer A, Ostareck DH . (2004). Control of mRNA translation and stability in haematopoietic cells: the function of hnRNPs K and E1/E2. Biol Cell 96: 407–411.

    Article  CAS  Google Scholar 

  • Pino I, Pio R, Toledo G, Zabalegui N, Vicent S, Rey N et al. (2003). Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein (hnRNP) family in lung cancer. Lung Cancer 41: 131–143.

    Article  Google Scholar 

  • Roychoudhury P, Chaudhuri K . (2007). Evidence for heterogeneous nuclear ribonucleoprotein K overexpression in oral squamous cell carcinoma. Br J Cancer 97: 574–575; author reply 576.

    Article  CAS  Google Scholar 

  • Schwartz EL, Wan E, Wang FS, Baptiste N . (1998). Regulation of expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in human colon carcinoma cells. Cancer Res 58: 1551–1557.

    CAS  PubMed  Google Scholar 

  • Seibel NM, Eljouni J, Nalaskowski MM, Hampe W . (2007). Nuclear localization of enhanced green fluorescent protein homomultimers. Anal Biochem 368: 95–99.

    Article  CAS  Google Scholar 

  • Tsai CL, Li HP, Lu YJ, Hsueh C, Liang Y, Chen CL et al. (2006). Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling. Cancer Res 66: 11668–11676.

    Article  CAS  Google Scholar 

  • Tse KP, Tsang NM, Chen KD, Li HP, Liang Y, Hsueh C et al. (2007). MCP-1 promoter polymorphism at 2518 is associated with metastasis of nasopharyngeal carcinoma after treatment. Clin Cancer Res 13: 6320–6326.

    Article  CAS  Google Scholar 

  • Waggoner SA, Liebhaber SA . (2003). Regulation of alpha-globin mRNA stability. Exp Biol Med (Maywood) 228: 387–395.

    Article  CAS  Google Scholar 

  • Wang S, Zhang J, Theel S, Barb JJ, Munson PJ, Danner RL . (2006). Nitric oxide activation of Erk1/2 regulates the stability and translation of mRNA transcripts containing CU-rich elements. Nucleic Acids Res 34: 3044–3056.

    Article  CAS  Google Scholar 

  • Yao Y, Kubota T, Sato K, Takeuchi H, Kitai R, Matsukawa S . (2005). Interferons upregulate thymidine phosphorylase expression via JAK-STAT-dependent transcriptional activation and mRNA stabilization in human glioblastoma cells. J Neurooncol 72: 217–223.

    Article  CAS  Google Scholar 

  • Zhu GH, Lenzi M, Schwartz EL . (2002). The Sp1 transcription factor contributes to the tumor necrosis factor-induced expression of the angiogenic factor thymidine phosphorylase in human colon carcinoma cells. Oncogene 21: 8477–8485.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Grant support was provided by the Ministry of Education, Taiwan (to Chang Gung University), the National Science Council, Taiwan (grants NSC 94-2314-B-182A-188, 94-3112-B-182-005 and 95-2320-B-182-001 to Y-S Chang) and Chang Gung Memorial Hospital, Taiwan (grants CMRPD150961 and CMRPG360221 to Y-S Chang). Special thanks to Chung Shan Medical University for supporting CL Liang to attend the 12th International EBV Symposium.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Y-S Chang.

Additional information

Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, LC., Liu, HP., Li, HP. et al. Thymidine phosphorylase mRNA stability and protein levels are increased through ERK-mediated cytoplasmic accumulation of hnRNP K in nasopharyngeal carcinoma cells. Oncogene 28, 1904–1915 (2009). https://doi.org/10.1038/onc.2009.55

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2009.55

Keywords

This article is cited by

Search

Quick links